References
- Carey JJ, Buehring B. Current imaging techniques in osteoporosis. Clin Exp Rheumatol. 2018;36(Suppl 114):115–126.
- Lee WC, Guntur AR, Long F, et al. Energy metabolism of the osteoblast: implications for osteoporosis. Endocr Rev. 2017;38:255–266.
- Yu W, Liu T, Valdez R, et al. Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes. BMC Med Inform Decis Mak. 2010;10:16.
- Klöppel S, Stonnington CM, Barnes J, et al. Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain. 2008;131:2969–2974.
- Das K, Giesbrecht B, Eckstein MP. Predicting variations of perceptual performance across individuals from neural activity using pattern classifiers. NeuroImage. 2010;51:1425–1437.
- Mourão-Miranda J, Bokde AL, Born C, et al. Classifying brain states and determining the discriminating activation patterns: support vector machine on functional MRI data. NeuroImage. 2005;28:980–995.
- Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–287.
- Daliri MR. Feature selection using binary particle swarm optimization and support vector machines for medical diagnosis. Biomed Tech. 2012;57:395–402.
- Dong J, Xu M. A 19‑miRNA support vector machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients. Oncol Rep. 2019;41:3233–3243.
- Liu K, Yang K, Wu B, et al. Tumor-infiltrating immune cells are associated with prognosis of gastric cancer. Medicine (Baltimore). 2015;94:e1631.
- Jiang Y, Zhang Q, Hu Y, et al. ImmunoScore signature: a prognostic and predictive tool in gastric cancer. Ann Surg. 2018;267:504–513.
- Jiang Y, Liu W, Li T, et al. Prognostic and predictive value of p21-activated kinase 6 associated support vector machine classifier in gastric cancer treated by 5-fluorouracil/oxaliplatin chemotherapy. EBioMedicine. 2017;22:78–88.
- Beam AL, Kohane IS. Translating artificial intelligence into clinical care. Jama. 2016;316:2368–2369.
- Liu Z, Liu Q, Chen S, et al. Circular RNA Circ_0005564 promotes osteogenic differentiation of bone marrow mesenchymal cells in osteoporosis. Bioengineered. 2021;12:4911–4923.
- Zhou R, Miao S, Xu J, et al. Circular RNA circ_0000020 promotes osteogenic differentiation to reduce osteoporosis via sponging microRNA miR-142-5p to up-regulate bone morphogenetic protein BMP2. Bioengineered. 2021;12:3824–3836.
- Han JH, Choi SJ, Kurihara N, et al. Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood. 2001;97:3349–3353.
- Roodman GD, Dougall WC. RANK ligand as a therapeutic target for bone metastases and multiple myeloma. Cancer Treat Rev. 2008;34:92–101.
- Lentzsch S, Gries M, Janz M, et al. Macrophage inflammatory protein 1-alpha (MIP-1 alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells. Blood. 2003;101:3568–3573.
- Son M, Diamond B, Volpe BT, et al. Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression. Sci Rep. 2017;7:270.
- Paul SP, Taylor LS, Stansbury EK, et al. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood. 2000;96:483–490.
- Quintrell N, Lebo R, Varmus H, et al. Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells. Mol Cell Biol. 1987;7:2267–2275.
- Bavi R, Kumar R, Rampogu S, et al. Novel virtual lead identification in the discovery of hematopoietic cell kinase (HCK) inhibitors: application of 3D QSAR and molecular dynamics simulation. J Recept Signal Transduct Res. 2017;37:224–238.
- Bhattacharjee A, Pal S, Feldman GM, et al. Hck is a key regulator of gene expression in alternatively activated human monocytes. J Biol Chem. 2011;286:36709–36723.
- Yang S, Blachowicz L, Makowski L, et al. Multidomain assembled states of Hck tyrosine kinase in solution. Proc Natl Acad Sci U S A. 2010;107:15757–15762.
- Gregori S, Tomasoni D, Pacciani V, et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood. 2010;116:935–944.
- Köstlin N, Ostermeir AL, Spring B, et al. HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4. Eur J Immunol. 2017;47:374–384.
- Shiroishi M, Kuroki K, Ose T, et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem. 2006;281:10439–10447.
- Kannengiesser C, Gérard B, El Benna J, et al. Molecular epidemiology of chronic granulomatous disease in a series of 80 kindreds: identification of 31 novel mutations. Hum Mutat. 2008;29:E132–49.
- Roos D, Kuhns DB, Maddalena A, et al. Hematologically important mutations: x-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45:246–265.
- Stasia MJ, Li XJ. Genetics and immunopathology of chronic granulomatous disease. Semin Immunopathol. 2008;30:209–235.
- Sumimoto H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. Febs J. 2008;275:3249–3277.